Temat: "Killer Cells, Natural" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma.
Autorzy :: Ohira M; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.; Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.
Hotta R; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Tanaka Y; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Matsuura T; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Tekin A; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Selvaggi G; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Vianna R; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.
Ricordi C; Cell Transplant Center, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Ruiz P; Department of Pathology and Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Nishida S; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA.; Department of Surgery, Westchester Medical Center, New York Medical College, Valhalla, NY, USA.
Tzakis AG; Department of Surgery, Division of Liver and Gastrointestinal Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA. .; Transplant Center, Cleveland Clinic, Cleveland, OH, USA. .; Transplant Center, Cleveland Clinic Florida, Weston, FL, USA. .
Ohdan H; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. .; Pokaż więcej
Źródło :: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Mar; Vol. 71 (3), pp. 589-599. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :: Journal Article
MeSH Terms :: Liver Transplantation*/adverse effects
Liver Transplantation*/methods
Carcinoma, Hepatocellular/*therapy
Killer Cells, Natural/*immunology
Killer Cells, Natural/*transplantation
Liver/*immunology
Liver Neoplasms/*therapy
Adoptive Transfer ; Adult ; Aged ; Biomarkers ; Combined Modality Therapy ; Feasibility Studies ; Female ; Graft Survival ; Humans ; Immunohistochemistry ; Killer Cells, Natural/metabolism ; Male ; Middle Aged ; Pilot Projects ; Treatment Outcome ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
Autorzy :: Thangaraj JL; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.; Department of Molecular Medicine, Chonnam National University, Gwangju, South Korea.
Phan MT; Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea.
Kweon S; Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea.; School of Interdisciplinary Bioscience and Bioengineering (I-Bio), POSTECH, Pohang, South Korea.
Kim J; Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea.; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.
Lee JM; Bio Research Center, Lugensci Co. Ltd., Bucheon, South Korea.
Hwang I; Department of Emergency Medicine, Konkuk University Chungju Hospital, Chungju, South Korea.
Park J; Research Institute of Advanced Materials, Seoul National University, Seoul, South Korea.
Doh J; Department of Materials Science and Engineering, Seoul National University, Seoul, South Korea.
Lee SH; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Vo MC; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Chu TH; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Molecular Medicine, Chonnam National University, Gwangju, South Korea.
Song GY; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Ahn SY; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Jung SH; Research Center for Cancer Immunotherapy, Gwangju, South Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Kim HJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
Cho D; Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea. .; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea. .; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-dong, Gangnam-gu, Seoul, 06351, Republic of Korea. .
Lee JJ; Research Center for Cancer Immunotherapy, Gwangju, South Korea. .; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea. .; Department of Molecular Medicine, Chonnam National University, Gwangju, South Korea. .; Pokaż więcej
Źródło :: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Mar; Vol. 71 (3), pp. 613-625. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :: Journal Article
MeSH Terms :: Cytotoxicity, Immunologic*/genetics
Interleukin-18/*metabolism
Interleukins/*metabolism
Killer Cells, Natural/*immunology
Lymphocyte Activation/*immunology
Multiple Myeloma/*immunology
OX40 Ligand/*metabolism
Cells, Cultured ; Coculture Techniques ; Gene Expression ; Humans ; Immunophenotyping ; Interleukin-18/genetics ; Interleukins/genetics ; K562 Cells ; Killer Cells, Natural/cytology ; Killer Cells, Natural/metabolism ; OX40 Ligand/genetics ; Transduction, Genetic ; Transgenes
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Differential expression of disparate transcription factor regime holds the key for NK cell development and function modulation.
Autorzy :: Rawat P; Department of Biotechnology, Delhi Technological University, Main Bawana Road, Delhi 110042, India.
Das A; Department of Biotechnology, Delhi Technological University, Main Bawana Road, Delhi 110042, India. Electronic address: .; Pokaż więcej
Źródło :: Life sciences [Life Sci] 2022 May 15; Vol. 297, pp. 120471. Date of Electronic Publication: 2022 Mar 09.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Killer Cells, Natural*
Transcription Factors*/metabolism
Female ; Gene Expression Regulation ; Humans ; Pregnancy ; Spleen/metabolism ; Uterus/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Intracellular infection and immune system cues rewire adipocytes to acquire immune function.
Autorzy :: Caputa G; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Matsushita M; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Sanin DE; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany; Bloomberg Kimmel Institute, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Kabat AM; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Edwards-Hicks J; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Grzes KM; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Pohlmeyer R; Imaging Facility, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Stanczak MA; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Castoldi A; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Cupovic J; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Forde AJ; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; Center for Chronic Immune Deficiency, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Apostolova P; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Seidl M; Center for Chronic Immune Deficiency, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany; Institute of Surgical Pathology, Faculty of Medicine, Medical Center, University of Freiburg, 79104 Freiburg, Germany; Institute of Pathology, Heinrich Heine University and University Hospital of Duesseldorf, 40225 Duesseldorf, Germany.
van Teijlingen Bakker N; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
Villa M; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Baixauli F; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Quintana A; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Hackl A; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Flachsmann L; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Hässler F; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Curtis JD; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Patterson AE; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Henneke P; Center for Chronic Immune Deficiency, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Pearce EL; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany; Bloomberg Kimmel Institute, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Department of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21287, USA. Electronic address: .
Pearce EJ; Department of Immunometabolism, Max Planck Institute for Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; Bloomberg Kimmel Institute, and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21287, USA. Electronic address: .; Pokaż więcej
Źródło :: Cell metabolism [Cell Metab] 2022 May 03; Vol. 34 (5), pp. 747-760.e6.
Typ publikacji :: Journal Article
MeSH Terms :: Cues*
Killer Cells, Natural*
Adipocytes/metabolism ; Immunity ; Interferon-gamma/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: The CD3ζ adaptor structure determines functional differences between human and mouse CD16 Fc receptor signaling.
Autorzy :: Aguilar OA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA.
Fong LK; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA.
Ishiyama K; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA.
DeGrado WF; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA.
Lanier LL; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA.; Pokaż więcej
Źródło :: The Journal of experimental medicine [J Exp Med] 2022 May 02; Vol. 219 (5). Date of Electronic Publication: 2022 Mar 23.
Typ publikacji :: Journal Article
MeSH Terms :: CD3 Complex*/genetics
Killer Cells, Natural*
Receptors, IgG*/genetics
Animals ; GPI-Linked Proteins ; Humans ; Mice ; Receptors, Fc ; Signal Transduction
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: A Single-Domain TCR-like Antibody Selective for the Qa-1 /Qdm Peptide Complex Enhances Tumoricidal Activity of NK Cells via Blocking the NKG2A Immune Checkpoint.
Autorzy :: Ghaffari S; Department of Biology, College of Science, The University of Texas at Arlington, Arlington, TX.
Upchurch-Ange K; Abexxa Biologics, Inc., Arlington, TX.
Gimlin S; Abexxa Biologics, Inc., Arlington, TX.
Tripathi T; Abexxa Biologics, Inc., Arlington, TX.
Sluijter M; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands; and.
Middelburg J; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands; and.
van Hall T; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands; and.
Weidanz J; Abexxa Biologics, Inc., Arlington, TX; .; College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, TX.; Pokaż więcej
Źródło :: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2022 May 01; Vol. 208 (9), pp. 2246-2255. Date of Electronic Publication: 2022 Apr 13.
Typ publikacji :: Journal Article
MeSH Terms :: Histocompatibility Antigens Class I*
Killer Cells, Natural*
Animals ; Antibodies/metabolism ; Mice ; NK Cell Lectin-Like Receptor Subfamily C/metabolism ; Peptides ; Receptors, Antigen, T-Cell/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Peripheral blood natural killer cells in sarcoidosis are associated with early cardiac involvement.
Autorzy :: Vakrakou AG; Neuroimmunology Laboratory, 1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Immunology and Histocompatibility Department, Evangelismos Hospital, Athens, Greece.
Kolilekas L; 7th Pulmonary Dept, Athens Chest Hospital 'Sotiria', Athens, Greece.
Lama N; Research Unit of Radiology and Medical Imaging, 2nd Department of Radiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Katsanos S; Department of Cardiology, Medical School, General University Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Stratakos G; Respiratory Medicine Department, Athens Chest Hospital 'Sotiria' Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Tsougos I; Department of Cardiology, Heart Failure and Preventive Cardiology Section, Ygeia Hospital, Athens, Greece.
Manali E; Pulmonary Medicine Department, Medical School, General University Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Grigoriou E; Immunology and Histocompatibility Department, Evangelismos Hospital, Athens, Greece.
Psarra K; Immunology and Histocompatibility Department, Evangelismos Hospital, Athens, Greece.
Kilidireas C; Neuroimmunology Laboratory, 1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.; First Department of Neurology, Medical School, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Papiris S; Pulmonary Medicine Department, Medical School, General University Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.
Kelekis NL; Research Unit of Radiology and Medical Imaging, 2nd Department of Radiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Gialafos EJ; Department of Cardiology, Medical School, General University Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.; First Department of Neurology, Medical School, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Pokaż więcej
Źródło :: European journal of clinical investigation [Eur J Clin Invest] 2022 May; Vol. 52 (5), pp. e13742. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji :: Journal Article
MeSH Terms :: Killer Cells, Natural*/pathology
Sarcoidosis*/pathology
Female ; Flow Cytometry ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Defective NK cell expansion, cytotoxicity, and lack of ability to differentiate tumors from a pancreatic cancer patient in a long term follow-up: implication in the progression of cancer.
Autorzy :: Kaur K; Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, Los Angeles, CA, USA.
Ko MW; Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, Los Angeles, CA, USA.
Chen F; Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, Los Angeles, CA, USA.
Jewett A; Division of Oral Biology and Oral Medicine, School of Dentistry and Medicine, Los Angeles, CA, USA. .; The Jonsson Comprehensive Cancer Center, UCLA School of Dentistry and Medicine, 10833 Le Conte Ave., Los Angeles, CA, 90095, USA. .; Pokaż więcej
Źródło :: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 May; Vol. 71 (5), pp. 1033-1047. Date of Electronic Publication: 2021 Sep 24.
Typ publikacji :: Journal Article
MeSH Terms :: Killer Cells, Natural*
Pancreatic Neoplasms*/diagnosis
Pancreatic Neoplasms*/pathology
Cross-Sectional Studies ; Cytotoxicity, Immunologic ; Humans ; Prospective Studies
SCR Disease Name :: Pancreatic Carcinoma
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Advancing natural killer therapies against cancer.
Autorzy :: Narni-Mancinelli E; Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France. Electronic address: .
Vivier E; Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; Innate Pharma Research Laboratories, Innate Pharma, Marseille, France; APHM, Hôpital de la Timone, Marseille-Immunopôle, Marseille, France.; Pokaż więcej
Źródło :: Cell [Cell] 2022 Apr 28; Vol. 185 (9), pp. 1451-1454.
Typ publikacji :: Journal Article
MeSH Terms :: Killer Cells, Natural*
Neoplasms*/pathology
Neoplasms*/therapy
Apoptosis ; Humans ; Immunotherapy, Adoptive ; Mitochondria/pathology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis.
Autorzy :: Pan R; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA. Electronic address: .
Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
Pan D; Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Wucherpfennig KW; Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA. Electronic address: .; Pokaż więcej
Źródło :: Cell [Cell] 2022 Apr 28; Vol. 185 (9), pp. 1521-1538.e18. Date of Electronic Publication: 2022 Apr 20.
Typ publikacji :: Journal Article
MeSH Terms :: Immunotherapy*
Killer Cells, Natural*
Neoplasms/*therapy
Apoptosis ; Neoplasms/pathology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: CD45RA ILCs in human tissues represent a quiescent local reservoir for the generation of differentiated ILCs.
Autorzy :: Kokkinou E; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Pandey RV; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Mazzurana L; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Gutierrez-Perez I; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Tibbitt CA; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Weigel W; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Soini T; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Carrasco A; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Rao A; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Nagasawa M; Department of Experimental Immunology, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
Bal SM; Department of Experimental Immunology, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
Jangard M; ENT Unit, Sophiahemmet University Research Laboratory and Sophiahemmet Hospital, Stockholm, Sweden.
Friberg D; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Lindforss U; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Nordenvall C; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Ljunggren M; Department of Molecular Medicine and Surgery, Karolinska Institutet and Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Haapaniemi S; Department of Surgery, Vrinnevi Hospital, Norrköping, Sweden.; Department of Surgery, Linköping University, Linköping, Sweden.
Keita ÅV; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Söderholm J; Department of Surgery, Linköping University, Linköping, Sweden.; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Hedin C; Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Gastroenterology Unit, Department of Gastroenterology, Dermatovenereology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Spits H; Department of Experimental Immunology, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
Bryceson YT; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Mjösberg J; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Pokaż więcej
Źródło :: Science immunology [Sci Immunol] 2022 Apr 15; Vol. 7 (70), pp. eabj8301. Date of Electronic Publication: 2022 Apr 15.
Typ publikacji :: Journal Article
MeSH Terms :: Immunity, Innate*
Killer Cells, Natural*
Cell Differentiation ; Humans ; Inflammation ; Lymphocyte Activation
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia.
Autorzy :: Albinger N; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany.
Pfeifer R; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Nitsche M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Mertlitz S; Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.
Campe J; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany.
Stein K; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany.
Kreyenberg H; Division for Stem Cell Transplantation, Immunology, and Intensive Care Medicine, Department for Children and Adolescents, University Hospital, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
Schubert R; Childrens Hospital, Pulmology and Allergology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
Quadflieg M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Schneider D; Lentigen Technology, Inc., a Miltenyi Biotec Company, Gaithersburg, MD, USA.
Kühn MWM; Department of Hematology, Medical Oncology, and Pulmonary Medicine, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Penack O; Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Zhang C; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Möker N; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Ullrich E; Childrens Hospital, Experimental Immunology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany. .; Frankfurt Cancer Institute, Johann Wolfgang Goethe University, Frankfurt am Main, Germany. .; University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany. .; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany. .; Pokaż więcej
Źródło :: Blood cancer journal [Blood Cancer J] 2022 Apr 13; Vol. 12 (4), pp. 61. Date of Electronic Publication: 2022 Apr 13.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Killer Cells, Natural*
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Animals ; Cell Line, Tumor ; Disease Models, Animal ; Hematopoiesis ; Humans ; Immunotherapy, Adoptive ; Mice ; Sialic Acid Binding Ig-like Lectin 3/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Presence of Natural Killer B Cells in Simian Immunodeficiency Virus-Infected Colon That Have Properties and Functions Similar to Those of Natural Killer Cells and B Cells but Are a Distinct Cell Population.
Autorzy :: Cogswell A; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.
Jo S; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.
Ferguson N; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.
Gupta K; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.
Barker E; Department of Microbial Pathogens and Immunity, Rush University Medical Centergrid.240684.c, Chicago, Illinois, USA.; Pokaż więcej
Źródło :: Journal of virology [J Virol] 2022 Apr 13; Vol. 96 (7), pp. e0023522. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Killer Cells, Natural*/immunology
Simian Acquired Immunodeficiency Syndrome*
Simian Immunodeficiency Virus*/immunology
Animals ; CD8-Positive T-Lymphocytes/immunology ; Colon/cytology ; Colon/immunology ; Colon/virology ; Cytokines/metabolism ; Inflammation/pathology ; Macaca mulatta ; Receptors, Natural Killer Cell/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Combination Blockade of the IL6R/STAT-3 Axis with TIGIT and Its Impact on the Functional Activity of NK Cells against Prostate Cancer Cells.
Autorzy :: González-Ochoa S; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.
Tellez-Bañuelos MC; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias Biológicas y Agropecuarias (CUCBA), Departamento de Biología Celular y Molecular, Las Agujas, 45220, Jalisco, Mexico.
Méndez-Clemente AS; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.
Bravo-Cuellar A; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de los Altos (CUALTOS), Departamento de Ciencias de la Salud, Tepatitlán de Morelos, 47620, Jalisco, Mexico.
Hernández Flores G; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.
Palafox-Mariscal LA; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.
Haramati J; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias Biológicas y Agropecuarias (CUCBA), Departamento de Biología Celular y Molecular, Las Agujas, 45220, Jalisco, Mexico.
Pedraza-Brindis EJ; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), HIV and Immunodeficiencies Research Institute, Clinical Medicine Department, Guadalajara, 44280, Jalisco, Mexico.; Universidad Autónoma de Guadalajara, Departamento Académico de Aparatos y Sistemas I, Unidad Académica de Ciencias de la Salud, Zapopan, 45129, Jalisco, Mexico.
Sánchez-Reyes K; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), HIV and Immunodeficiencies Research Institute, Clinical Medicine Department, Guadalajara, 44280, Jalisco, Mexico.
Ortiz-Lazareno PC; Instituto Mexicano del Seguro Social (IMSS), Centro de Investigación Biomédica de Occidente (CIBO), División de Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud (CUCS), Programa de Doctorado en Ciencias Biomédicas Orientación Inmunología, Guadalajara, 44340, Jalisco, Mexico.; Pokaż więcej
Źródło :: Journal of immunology research [J Immunol Res] 2022 Apr 12; Vol. 2022, pp. 1810804. Date of Electronic Publication: 2022 Apr 12 (Print Publication: 2022).
Typ publikacji :: Journal Article
MeSH Terms :: Killer Cells, Natural*/metabolism
Prostatic Neoplasms*/metabolism
Humans ; Male ; Prostate/metabolism ; Receptors, Immunologic/metabolism ; Receptors, Interleukin-6
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation.
Autorzy :: Fang D; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: .
Cui K; Laboratory of Epigenome Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Cao Y; Laboratory of Epigenome Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Zheng M; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Microbiology and Immunology School of Medicine, Jiangsu Provincial Key Laboratory of Critical Care Medicine, Southeast University, Nanjing, Jiangsu 210009, China.
Kawabe T; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Hu G; Laboratory of Epigenome Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA; Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, WV 26506, USA.
Khillan JS; Mouse Genetics and Gene Modification Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Li D; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Clinical Laboratory, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.
Zhong C; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Jankovic D; Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Sher A; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Zhao K; Laboratory of Epigenome Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Zhu J; Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: .; Pokaż więcej
Źródło :: Immunity [Immunity] 2022 Apr 12; Vol. 55 (4), pp. 639-655.e7. Date of Electronic Publication: 2022 Apr 04.
Typ publikacji :: Journal Article
MeSH Terms :: Immunity, Innate*
Interleukin-18*/metabolism
Killer Cells, Natural*/immunology
Th1 Cells*/immunology
Cell Differentiation ; T-Box Domain Proteins/metabolism ; Transcription Factors/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Neutrophil and natural killer cell imbalances prevent muscle stem cell-mediated regeneration following murine volumetric muscle loss.
Autorzy :: Larouche JA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Fraczek PM; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Kurpiers SJ; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.
Yang BA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Davis C; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109.
Castor-Macias JA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Sabin K; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
Anderson S; Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332.
Harrer J; Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332.
Hall M; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.
Brooks SV; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48109.
Jang YC; Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332.; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332.
Willett N; Phil and Penny Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR 97403.
Shea LD; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.
Aguilar CA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109.; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.; Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI 48109.; Pokaż więcej
Źródło :: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Apr 12; Vol. 119 (15), pp. e2111445119. Date of Electronic Publication: 2022 Apr 04.
Typ publikacji :: Journal Article
MeSH Terms :: Killer Cells, Natural*/immunology
Muscle, Skeletal*/immunology
Muscle, Skeletal*/pathology
Muscular Diseases*/immunology
Muscular Diseases*/pathology
Neutrophils*/immunology
Regeneration*/immunology
Satellite Cells, Skeletal Muscle*/immunology
Animals ; Fibrosis ; Mice ; Neutrophil Infiltration ; Transforming Growth Factor beta/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: ILC killer: Qu'est-ce que c'est?
Autorzy :: Withers DR; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Hepworth MR; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Pokaż więcej
Źródło :: Science immunology [Sci Immunol] 2022 Apr 08; Vol. 7 (70), pp. eabo2159. Date of Electronic Publication: 2022 Apr 08.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Immunity, Innate*
Killer Cells, Natural*
Animals ; Mice
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo .
Autorzy :: Oyer JL; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Croom-Perez TJ; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Dieffenthaller TA; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Robles-Carillo LD; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Gitto SB; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.; Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Altomare DA; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.
Copik AJ; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.; Pokaż więcej
Źródło :: Frontiers in immunology [Front Immunol] 2022 Apr 07; Vol. 13, pp. 861681. Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022).
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Killer Cells, Natural*/metabolism
Neoplasms*/therapy
Animals ; Cryopreservation ; Humans ; Immunotherapy/methods ; Immunotherapy, Adoptive ; Mice
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity.
Autorzy :: Bernareggi D; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Xie Q; Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
Prager BC; Department of Medicine, University of California San Diego, La Jolla, CA, USA.; Cleveland Clinic Lerner College of Medicine at Cleveland Clinic & Case Western Reserve University, Cleveland, OH, USA.
Yun J; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Cruz LS; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Pham TV; Center for Novel Therapeutics and Moores Cancer Center, UCSD, San Diego, CA, USA.
Kim W; Center for Novel Therapeutics and Moores Cancer Center, UCSD, San Diego, CA, USA.; Division of Medical Genetics, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Lee X; Department of Oncology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
Coffey M; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Zalfa C; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Azmoon P; Department of Pathology, University of California San Diego, La Jolla, CA, USA.
Zhu H; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Tamayo P; Center for Novel Therapeutics and Moores Cancer Center, UCSD, San Diego, CA, USA.; Division of Medical Genetics, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Rich JN; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Kaufman DS; Department of Medicine, University of California San Diego, La Jolla, CA, USA. .; Pokaż więcej
Źródło :: Nature communications [Nat Commun] 2022 Apr 07; Vol. 13 (1), pp. 1899. Date of Electronic Publication: 2022 Apr 07.
Typ publikacji :: Journal Article
MeSH Terms :: Head and Neck Neoplasms*/genetics
Killer Cells, Natural*
Animals ; Apoptosis/genetics ; Cell Line, Tumor ; Cytotoxicity, Immunologic ; Endosomal Sorting Complexes Required for Transport ; Humans ; Immunotherapy ; Mice ; Squamous Cell Carcinoma of Head and Neck/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Assessment of the Levels of Peripheral Lymphocytes Subpopulation in Healthy Women of Childbearing Age: a Prospective Cohort Study.
Autorzy :: Li G
Ding Q
Deng X
Bao S; Pokaż więcej
Źródło :: Clinical laboratory [Clin Lab] 2022 Apr 01; Vol. 68 (4).
Typ publikacji :: Journal Article
MeSH Terms :: Killer Cells, Natural*
Lymphocyte Subsets*
Antigens, CD19 ; CD8-Positive T-Lymphocytes ; Female ; Humans ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Killer Cells, Natural"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język